RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Autoimmunity and interferon β lB
1997 Lugaresi A.; Capasso M.; De Luca G.; Farina D.; Larlori C.; Marzoli F.; Gambi D.
Autologous stem cell transplantation International multiple sclerosis (ASTIMS) trial: a randomized, phase II, controlled, multicentre trial
2012 D. Currò; M. Sormani; F. Gualandi; A. Saiz; E. Carreras; E. Merelli; A. Donelli; A. Lugaresi; P. Di Bartolomeo; A. Rambaldi; M. Rottoli; . Amato; L. Massacesi; M. Di Gioia; L. Vuolo; L. Roccatagliata; E. Capello; A. Uccelli; P. Iacopino; U. Aguglia; M. Filippi; R. Saccardi; G. Mancardi
Baseline Patient and Caregiver Characteristics From a Prospective, Noninterventional, Real-World Study (REALITY) on the Effect of Alemtuzumab on Fatigue and Other Patient- and Caregiver-Reported Quality-of-Life Outcomes in Patients With RRMS
2020 Eriksen, S; van Exel, J; Frederiksen, JL; Nielsen, HH; Torkildsen, O; Rini, A; Massacesi, L; Mondino, M; Mirabella, M; Lugaresi, A; Lus, G; Paolicelli, D; Caniatti, LM; Tsai, JA; Scarpini, E
Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry
2018 Spelman, T; Harvrdova, EK; Horakova, D; Izquierdo, G; Kalincik, T; Lugaresi, A; Onofrj, M; Duquette, P; Girard, M; Prat, A; Grammond, P; Grand'Maison, F; Granella, F; Lechner-Scott, J; Sola, P; Ferrero, D; Sá, MJ; Terzi, M; Ozakbas, S; Van Pesch, V; Van Wijmeersch, B; Boz, C; Karabudak, R; Cartechini, E; McCombe, P; Butzkueven, H
Comparative efficacy of switch to natalizumab of fingolimod in active relapsing.remitting multiple sclerosis
2014 T. Kalincik; D. Horakova; T. Spelman; V. Jokubaitis; M. Trojano; A. Lugaresi; G. Izquierdo; C. Rozsa; P.Grammond; R. Alroughani; P. Duquette; M. Girard; E. Pucci; J. Lechner-Scott; M. Slee; R. Fernandez-Bolanos; F. Grand’Maison; R. Hupperts; F. Verheul; S. Hodgkinson; C. Oreja-Guevara; D. Spitalieri; M. Barnett; M. Terzi; R. Bergamaschi; P. McCombe; J. Sanchez- Menoyo; M. Simo; T. Csepany; G. Rum; C. Boz; E. Havrdova; H. Butzkueven; Ms Base Study Group.
Comparison of fingolimod versus interferon-beta/glatiramer acetate as second-line therapy in active multiple sclerosis
2014 A. He; T. Spelman; V Jokubaitis; A. Lugaresi; G. Izquiero; M. Trojano; P. Grammond; J. Lechner-Scott; P. Duquette; M. Girard; E. Pucci; M. Slee; F. Grand’Maison; C . Oreja-Guevara; C. Boz; R. Fernandez-Bolanos; S. Hodgkinson; J. Sanchez-Menoyo; G. Iuliano; M. Barnett; F. Moore; H. Butzkueven; T. Kalincik; Ms Base Study Group.
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis
2012 V. Di Tommaso; D. Farina; G. De Luca; M. Di Ioia; L. Mancinelli; E. Pietrolongo; D. Travaglini; A. Lugaresi
Delayed appearance of ulnar neuropathy following interferon-beta injection
2004 Capasso, M; Caulo, M; De Luca, G; Magarelli, N; Lugaresi, A
Development of an abbreviated, computerized version of the MSQOL-54 using confirmatory factory analysis and item response theory.
2015 Rosato R.; Testa S.; Bertolotto A.; Confalonieri P.; Patti F.; Lugaresi A.; Grasso Mg; Vickrey B.; Giordano A.; Solari A.
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients
2014 M. di Ioia; D. Pieragostino; C. Rossi; M. Zucchelli; M. D’Alessandro; A. Lugaresi; D. Travaglini; D. Farina; P. Sacchetta; P. Del Boccio
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Autoimmunity and interferon β lB | Lugaresi A.; Capasso M.; De Luca G.; Farina D.; Larlori C.; Marzoli F.; Gambi D. | 1997-01-01 | ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES | - | 1.06 Abstract in rivista | - |
Autologous stem cell transplantation International multiple sclerosis (ASTIMS) trial: a randomized, phase II, controlled, multicentre trial | D. Currò; M. Sormani; F. Gualandi; A. Saiz; E. Carreras; E. Merelli; A. Donelli; A. Lugaresi; P. ...Di Bartolomeo; A. Rambaldi; M. Rottoli; . Amato; L. Massacesi; M. Di Gioia; L. Vuolo; L. Roccatagliata; E. Capello; A. Uccelli; P. Iacopino; U. Aguglia; M. Filippi; R. Saccardi; G. Mancardi | 2012-01-01 | NEUROLOGICAL SCIENCES | - | 1.06 Abstract in rivista | - |
Baseline Patient and Caregiver Characteristics From a Prospective, Noninterventional, Real-World Study (REALITY) on the Effect of Alemtuzumab on Fatigue and Other Patient- and Caregiver-Reported Quality-of-Life Outcomes in Patients With RRMS | Eriksen, S; van Exel, J; Frederiksen, JL; Nielsen, HH; Torkildsen, O; Rini, A; Massacesi, L; Mond...ino, M; Mirabella, M; Lugaresi, A; Lus, G; Paolicelli, D; Caniatti, LM; Tsai, JA; Scarpini, E | 2020-01-01 | NEUROLOGY | - | 1.06 Abstract in rivista | - |
Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry | Spelman, T; Harvrdova, EK; Horakova, D; Izquierdo, G; Kalincik, T; Lugaresi, A; Onofrj, M; Duquet...te, P; Girard, M; Prat, A; Grammond, P; Grand'Maison, F; Granella, F; Lechner-Scott, J; Sola, P; Ferrero, D; Sá, MJ; Terzi, M; Ozakbas, S; Van Pesch, V; Van Wijmeersch, B; Boz, C; Karabudak, R; Cartechini, E; McCombe, P; Butzkueven, H | 2018-01-01 | MULTIPLE SCLEROSIS | - | 1.06 Abstract in rivista | - |
Comparative efficacy of switch to natalizumab of fingolimod in active relapsing.remitting multiple sclerosis | T. Kalincik; D. Horakova; T. Spelman; V. Jokubaitis; M. Trojano; A. Lugaresi; G. Izquierdo; C. Ro...zsa; P.Grammond; R. Alroughani; P. Duquette; M. Girard; E. Pucci; J. Lechner-Scott; M. Slee; R. Fernandez-Bolanos; F. Grand’Maison; R. Hupperts; F. Verheul; S. Hodgkinson; C. Oreja-Guevara; D. Spitalieri; M. Barnett; M. Terzi; R. Bergamaschi; P. McCombe; J. Sanchez- Menoyo; M. Simo; T. Csepany; G. Rum; C. Boz; E. Havrdova; H. Butzkueven; Ms Base Study Group. | 2014-01-01 | MULTIPLE SCLEROSIS | - | 1.06 Abstract in rivista | - |
Comparison of fingolimod versus interferon-beta/glatiramer acetate as second-line therapy in active multiple sclerosis | A. He; T. Spelman; V Jokubaitis; A. Lugaresi; G. Izquiero; M. Trojano; P. Grammond; J. Lechner-Sc...ott; P. Duquette; M. Girard; E. Pucci; M. Slee; F. Grand’Maison; C . Oreja-Guevara; C. Boz; R. Fernandez-Bolanos; S. Hodgkinson; J. Sanchez-Menoyo; G. Iuliano; M. Barnett; F. Moore; H. Butzkueven; T. Kalincik; Ms Base Study Group. | 2014-01-01 | MULTIPLE SCLEROSIS | - | 1.06 Abstract in rivista | - |
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis | V. Di Tommaso; D. Farina; G. De Luca; M. Di Ioia; L. Mancinelli; E. Pietrolongo; D. Travaglini; A.... Lugaresi | 2012-01-01 | NEUROLOGICAL SCIENCES | - | 1.06 Abstract in rivista | - |
Delayed appearance of ulnar neuropathy following interferon-beta injection | Capasso, M; Caulo, M; De Luca, G; Magarelli, N; Lugaresi, A | 2004-01-01 | JOURNAL OF NEUROIMMUNOLOGY | - | 1.06 Abstract in rivista | - |
Development of an abbreviated, computerized version of the MSQOL-54 using confirmatory factory analysis and item response theory. | Rosato R.; Testa S.; Bertolotto A.; Confalonieri P.; Patti F.; Lugaresi A.; Grasso Mg; Vickrey B....; Giordano A.; Solari A. | 2015-01-01 | INTERNATIONAL MS JOURNAL | - | 1.06 Abstract in rivista | - |
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients | M. di Ioia; D. Pieragostino; C. Rossi; M. Zucchelli; M. D’Alessandro; A. Lugaresi; D. Travaglini;... D. Farina; P. Sacchetta; P. Del Boccio | 2014-01-01 | NEUROLOGICAL SCIENCES | - | 1.06 Abstract in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 - Contributo in rivista 88
- 1 - Contributo in rivista::1.06 A... 88
Data di pubblicazione
- 2020 - 2022 2
- 2010 - 2019 78
- 2000 - 2009 3
- 1997 - 1999 5
Rivista
- NEUROLOGICAL SCIENCES 38
- MULTIPLE SCLEROSIS 33
- NEUROLOGY 6
- ITALIAN JOURNAL OF NEUROLOGICAL S... 5
- INTERNATIONAL MS JOURNAL 3
- JOURNAL OF NEUROIMMUNOLOGY 1
- JOURNAL OF NEUROIMMUNOLOGY. SUPPL... 1
- LIFE SCIENCES 1
Keyword
- multiple sclerosis 71
- treatment 16
- natalizumab 12
- safety 12
- prognosis 11
- pregnancy 10
- efficacy 8
- glatiramer acetate 7
- cognition 5
- fingolimod 5
Lingua
- eng 88
Accesso al fulltext
- no fulltext 88